Fig 3. Risks of all types of cardiovascular diseases associated with non-steroidal anti-inflammatory drugs (NSAIDs).
(A) Total NSAIDs, (B) specific cyclooxygenase II (COX II) inhibitors, (C) non-selective NSAIDs. NSAID exposure was categorized into non-users, MPR<80% and MPR≥80%. The data were adjusted by the CCI and other drugs used.